<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05115305</url>
  </required_header>
  <id_info>
    <org_study_id>ProdigyValidationStudy</org_study_id>
    <nct_id>NCT05115305</nct_id>
  </id_info>
  <brief_title>Prodigy, a Level 2 Sleep Study Device, Validation Study</brief_title>
  <official_title>Validation of a Level 2 Sleep Study Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cerebra Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cerebra Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same&#xD;
      information in the home that is currently only obtained in in-laboratory studies.&#xD;
&#xD;
      The objective of the current study is to demonstrate that the signals obtained by this&#xD;
      comprehensive, portable system are comparable to those obtained in in-laboratory studies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of obtaining standard polysomnography signals concurrently by the Prodigy&#xD;
      2 and by the standard commercial systems used in the Sleep Disorders Clinic (Alice G3) in&#xD;
      Hamilton, ON and the St. Charles Sleep Disorders Center (Nihon Kohden) in Port Jefferson, NY.&#xD;
      42 patients will be recruited from each of the two sites, for a total of 84 patients.&#xD;
      Questionnaires on demographics and mental health, including the Depression Anxiety Stress&#xD;
      Scale-21, questionnaires on sleep and fatigue including Pittsburgh Sleep Quality Index,&#xD;
      Insomnia Severity Index, and Epworth Sleepiness Scale and questionnaires on quality of life&#xD;
      including the Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10) and the Euroquol 5D-5L&#xD;
      will be completed online using a survey platform (Qualtrics or RedCap).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total Sleep Time</measure>
    <time_frame>Concurrent measurement for one night</time_frame>
    <description>To compare Level 1 and Level 2 sleep tests on TST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>Concurrent measurement for one night</time_frame>
    <description>To compare Level 1 and Level 2 sleep tests on AHI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Periodic Limb Movement Index</measure>
    <time_frame>Concurrent measurement for one night</time_frame>
    <description>To visually compare Level 1 and Level 2 sleep tests on PLM</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Signal Quality</measure>
    <time_frame>Concurrent measurement for one night</time_frame>
    <description>To compare signal quality between Level 1 and Level 2 sleep tests</description>
  </secondary_outcome>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Comparison of Devices</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited from patients referred to either sleep clinic to undergo a&#xD;
        diagnostic sleep test.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing a diagnostic sleep test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  in-hospital patients&#xD;
&#xD;
          -  subjects who self-report a previous diagnosis of neuromuscular disorders, obesity&#xD;
             hypoventilation, or severe lung disease&#xD;
&#xD;
          -  subjects who are not fluent in English, or who have special communication needs&#xD;
&#xD;
          -  subjects who have dementia/Alzheimer's disease&#xD;
&#xD;
          -  subjects with comorbid violent parasomnias&#xD;
&#xD;
          -  subjects requiring additional assistance or who have limited ability follow commands.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Amy Bender, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cerebra Medical</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raymond Gottschalk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamilton Sleep Disorders Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad Amin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Charles Sleep Disorders Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Bender, PhD</last_name>
    <phone>5877038664</phone>
    <email>amy.bender@cerebrahealth.com</email>
  </overall_contact>
  <reference>
    <citation>Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43.</citation>
    <PMID>7726811</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.</citation>
    <PMID>2748771</PMID>
  </reference>
  <reference>
    <citation>Morin CM, Belleville G, BÃ©langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8.</citation>
    <PMID>21532953</PMID>
  </reference>
  <reference>
    <citation>Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5.</citation>
    <PMID>1798888</PMID>
  </reference>
  <reference>
    <citation>Chasens ER, Ratcliffe SJ, Weaver TE. Development of the FOSQ-10: a short version of the Functional Outcomes of Sleep Questionnaire. Sleep. 2009 Jul;32(7):915-9.</citation>
    <PMID>19639754</PMID>
  </reference>
  <reference>
    <citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.</citation>
    <PMID>21479777</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prodigy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

